Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-Apr-21 8:42 PM View:  | Intellia Therapeutics, Inc. (NTLA) | 01-Apr-21 | Option Exercise | 97,001 | $12.51 | $1,213,540.00 | 26% 378.05K to 475.05K | |
| 02-Apr-21 8:42 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Apr-21 | Market Option Sale (Planned) | 50,455 | $82.46 | $4,160,560.00 | (11%) 475.05K to 424.6K | |
| 09-Feb-21 8:38 PM View: | Intellia Therapeutics, Inc. (NTLA) | 09-Feb-21 | Option Exercise | 21,000 | $18.30 | $384,195.00 | 6% 370.62K to 391.62K | |
| 09-Feb-21 8:38 PM View: | Intellia Therapeutics, Inc. (NTLA) | 09-Feb-21 | Market Option Sale (Planned) | 11,489 | $75.00 | $861,675.00 | (3%) 391.62K to 380.13K | |
| 03-Feb-21 9:38 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Feb-21 | Option Exercise | 109,000 | $9.68 | $1,054,620.00 | 34% 316.28K to 425.28K | |
| 03-Feb-21 9:38 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Feb-21 | Market Option Sale (Planned) | 54,659 | $63.99 | $3,497,900.00 | (13%) 425.28K to 370.62K | |
| 05-Jan-21 8:55 PM View: | Intellia Therapeutics, Inc. (NTLA) | 05-Jan-21 | Market Option Sale | 2,078 | $55.86 | $116,077.00 | (< 1%) 316.28K to 314.2K | |
| 05-Jan-21 8:55 PM View: | Intellia Therapeutics, Inc. (NTLA) | 31-Dec-20 | Option Exercise | 4,792 | -- | -- | 2% 311.49K to 316.28K | |
| 03-Dec-20 6:42 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Dec-20 | Option Exercise | 5,000 | $13.88 | $69,400.00 | 2% 309.28K to 314.28K | 4% |
| 03-Dec-20 6:42 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Dec-20 | Market Option Sale (Planned) | 3,364 | $38.21 | $128,525.00 | (1%) 314.28K to 310.92K | (63%) |
| 18-Nov-20 7:55 PM View: | Intellia Therapeutics, Inc. (NTLA) | 18-Nov-20 | Option Exercise | 848 | $18.30 | $15,518.40 | < 1% 309.06K to 309.91K | |
| 18-Nov-20 7:55 PM View: | Intellia Therapeutics, Inc. (NTLA) | 18-Nov-20 | Market Option Sale (Planned) | 624 | $35.00 | $21,840.00 | (< 1%) 309.91K to 309.28K | (78%) |
| 18-Nov-20 7:55 PM View: | Intellia Therapeutics, Inc. (NTLA) | 16-Nov-20 | Option Exercise | 10,562 | $7.44 | $78,584.60 | 3% 304.52K to 315.09K | |
| 18-Nov-20 7:55 PM View: | Intellia Therapeutics, Inc. (NTLA) | 16-Nov-20 | Market Option Sale (Planned) | 6,029 | $34.29 | $206,728.00 | (2%) 315.09K to 309.06K | (81%) |
| 06-Nov-20 4:41 PM View: | Intellia Therapeutics, Inc. (NTLA) | 04-Nov-20 | Option Exercise | 5,000 | $13.88 | $69,400.00 | 2% 302.89K to 307.89K | 4% |
| 06-Nov-20 4:41 PM View: | Intellia Therapeutics, Inc. (NTLA) | 04-Nov-20 | Market Option Sale (Planned) | 3,364 | $28.00 | $94,192.00 | (1%) 307.89K to 304.52K | (122%) |
| 16-Oct-20 8:58 PM View: | Intellia Therapeutics, Inc. (NTLA) | 15-Oct-20 | Option Exercise | 10,000 | $6.83 | $68,300.00 | 3% 298.5K to 308.5K | |
| 16-Oct-20 8:58 PM View: | Intellia Therapeutics, Inc. (NTLA) | 15-Oct-20 | Market Option Sale (Planned) | 5,615 | $24.20 | $135,883.00 | (2%) 308.5K to 302.89K | (157%) |
| 17-Sep-20 4:55 PM View: | Intellia Therapeutics, Inc. (NTLA) | 15-Sep-20 | Option Exercise | 10,000 | $6.83 | $68,300.00 | 3% 294.12K to 304.12K | |
| 17-Sep-20 4:55 PM View: | Intellia Therapeutics, Inc. (NTLA) | 15-Sep-20 | Market Option Sale (Planned) | 5,615 | $21.04 | $118,140.00 | (2%) 304.12K to 298.5K | (195%) |
| 20-Aug-20 4:13 PM View: | Intellia Therapeutics, Inc. (NTLA) | 18-Aug-20 | Option Exercise | 10,000 | $6.83 | $68,300.00 | 3% 289.73K to 299.73K | |
| 20-Aug-20 4:13 PM View: | Intellia Therapeutics, Inc. (NTLA) | 18-Aug-20 | Market Option Sale (Planned) | 5,615 | $21.00 | $117,915.00 | (2%) 299.73K to 294.12K | (196%) |
| 17-Jul-20 4:18 PM View: | Intellia Therapeutics, Inc. (NTLA) | 15-Jul-20 | Option Exercise | 10,000 | $6.83 | $68,300.00 | 4% 285.35K to 295.35K | |
| 17-Jul-20 4:18 PM View: | Intellia Therapeutics, Inc. (NTLA) | 15-Jul-20 | Market Option Sale (Planned) | 5,615 | $22.70 | $127,461.00 | (2%) 295.35K to 289.73K | (174%) |
| 18-Jun-20 5:00 PM View: | Intellia Therapeutics, Inc. (NTLA) | 16-Jun-20 | Option Exercise | 10,000 | $6.83 | $68,300.00 | 4% 280.11K to 290.11K | |
| 18-Jun-20 5:00 PM View: | Intellia Therapeutics, Inc. (NTLA) | 16-Jun-20 | Market Option Sale (Planned) | 5,615 | $21.00 | $117,915.00 | (2%) 290.11K to 284.49K | (196%) |
| 28-May-20 5:23 PM View: | Intellia Therapeutics, Inc. (NTLA) | 26-May-20 | Option Exercise | 10,000 | $6.83 | $68,300.00 | 4% 275.72K to 285.72K | |
| 28-May-20 5:23 PM View: | Intellia Therapeutics, Inc. (NTLA) | 26-May-20 | Market Option Sale (Planned) | 5,615 | $21.21 | $119,094.00 | (2%) 285.72K to 280.11K | (193%) |
| 05-Jun-17 7:57 AM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Jun-17 | Grant | 8,400 | $12.03 | $101,075.00 | 3% 262.8K to 271.2K | 415% |